Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT00926757
Eligibility Criteria:
Inclusion Criteria:
* CD20 positive lymphoma
* negative for HBsAg and positive for anti-HBc
* age over 16 years old
* alanine aminotransferase less than 2 times the upper limit of normal
* bilirubin \< 2.5 mg/dL
* neutrophil \> 2000/mm3
* platelet \> 100,000/mm3
* creatinine \< 1.5 mg/dL
* urea nitrogen \< 25 mg/dL
* Eastern Cooperative Oncology Group performance score 0 to 2
Exclusion Criteria:
* Child-Pugh class B or C cirrhosis
* grade 2 or greater heart failure by the NYHA classification
* previous chemotherapy,radiotherapy, or concurrent glucocorticoid therapy for other reasons
* other primary liver diseases, such as chronic hepatitis C, hepatitis D, autoimmune hepatitis, or Wilsons' disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00926757
Study Brief:
Protocol Section:
NCT00926757